Merck KGaA
Procter & Gamble to buy the consumer health business of Merck KGaA for $4.2 bn
20 Apr 2018
As part of the deal, P&G will acquire a majority stake of 51.80 per cent stake in India listed drug firm Merck Ltd for Rs 1,289.88 crore and subsequently make a mandatory tender offer to minority shareholders
Nestle, Bain Capital, Cinven in race for Merck KgaA’s consumer health unit
02 Dec 2017
Swiss food giant Nestle and private equity firms Bain Capital and Cinven – owners of German drug firm Stada — are in the race to buy Merck KgaA’s consumer health unit
Merck KGaA mulls splitting into three companies
17 May 2017
German diversified conglomerate Merck KGaA is mulling shifting its chemicals, healthcare and biotech supplies operations into separate entities next year so that the three business units could be better managed
Merck to pay Threshold up to $525 million for cancer drug development
06 Feb 2012
Darmstadt-based Merck will receive co-development rights, exclusive global marketing rights and will provide Threshold an option to co-market the drug in the US
